|
Human albumin is an essential protein found in human plasma and accounts for about 50%-60% of plasma proteins.1 Each molecule is composed of three units, or domains, which function together to give albumin its unique binding properties.3 It is the primary agent responsible for maintaining osmotic pressure of the blood,
|
www.albumintherapy.com/albumin_therapy/what_is_albumin....
www.albumintherapy.com/albumin_therapy/what_is_albumin.html
|
|
|
In the United States, the indications for which albumin therapy are considered include hypovolemia or shock, burns, hypoalbuminemia, surgery or trauma, cardiopulmonary bypass, acute respiratory distress syndrome, hemodialysis, and sequestration of protein-rich fluids.
|
ncp.sagepub.com/cgi/content/abstract/20/3/314
|
|
|
The Medscape Journal ... Allergy & Clinical Immunology ... 0 (Serum Albumin)
|
www.medscape.com/medline/abstract/12394941
|
|
|
Why is albumin important? ... What causes serum albumin to decrease? ... Consequences of decreased plasma albumin...
|
www.4um.com/tutorial/currents/albumin.htm
www.4um.com/tutorial/currents/albumin.htm
|
|
Albumin is a protein normally found in blood. Solutions of human albumin can be given to patients through their veins (intravenously). These products are expensive and sometimes difficult to get. ... Albumin is usually given to people who are very ill, such as those who have severe burns, serious trauma, major surgery,
|
www.annals.org/content/135/3/S25.full
|
|
COMPTON, England - Baxter Healthcare Ltd announced today the introduction of BAXJECT II, an innovative needle-less reconstitution device and an improved packaging design for its plasma-albumin-free haemophilia A therapy ADVATE.
|
www.medicalnewstoday.com/articles/50106.php
|
|
Our initial findings suggest that albumin therapy is superior to standard crystalloid therapy, in the treatment of HRS patients. The number of survival days ...
|
www.ncbi.nlm.nih.gov/pmc/articles/PMC1480134/
|
|
Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderat...Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
|
www.ncbi.nlm.nih.gov/pubmed/11157196
|
|
Human albumin (ALB) therapy is highly neuroprotective in preclinical models of cerebral ischemia. Multiple mechanisms underlie ALB's efficacy: fatty-acid and transition-metal binding, antioxidant and oncotic actions, and salutary microcirculatory effects...
|
www.nature.com/jcbfm/journal/v25/n1s/full/9591524.0115a...
www.nature.com/jcbfm/journal/v25/n1s/full/9591524.0115a.html
|
|
